Selected research
Industry Research
Amodiaquine Tablets Industry Research Report 2026
Market perspective
The global Amodiaquine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amodiaquine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amodiaquine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amodiaquine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amodiaquine Tablets include Actiza Pharmaceutical, AdvaCare Pharma, DevLife Corporation, Healthy Life Pharma, Micro Labs, SiNi Pharma, Sunrise and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amodiaquine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amodiaquine Tablets Market by Company
Actiza Pharmaceutical
AdvaCare Pharma
DevLife Corporation
Healthy Life Pharma
Micro Labs
SiNi Pharma
Sunrise
Wellona Pharma
Amodiaquine Tablets Segment by Type
100 mg
200 mg
600 mg
Others
Amodiaquine Tablets Segment by Application
Hospitals
Clinics
Pharmacy
Amodiaquine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amodiaquine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amodiaquine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amodiaquine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amodiaquine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amodiaquine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amodiaquine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100 mg
- 200 mg
- 600 mg
- Others
Applications
- Hospitals
- Clinics
- Pharmacy
Companies covered
- Actiza Pharmaceutical
- AdvaCare Pharma
- DevLife Corporation
- Healthy Life Pharma
- Micro Labs
- SiNi Pharma
- Sunrise
- Wellona Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amodiaquine Tablets Market Size (2021-2032)
- 2.2.2 Global Amodiaquine Tablets Sales (2021-2032)
- 2.2.3 Global Amodiaquine Tablets Market Average Price (2021-2032)
- 2.3 Amodiaquine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 100 mg
- 2.3.3 200 mg
- 2.3.4 600 mg
- 2.3.5 Others
- 2.4 Amodiaquine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amodiaquine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amodiaquine Tablets Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Amodiaquine Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Amodiaquine Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Amodiaquine Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amodiaquine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amodiaquine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Amodiaquine Tablets, Established Date
- 3.9 Global Amodiaquine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actiza Pharmaceutical
- 4.1.1 Actiza Pharmaceutical Company Information
- 4.1.2 Actiza Pharmaceutical Business Overview
- 4.1.3 Actiza Pharmaceutical Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actiza Pharmaceutical Amodiaquine Tablets Product Portfolio
- 4.1.5 Actiza Pharmaceutical Recent Developments
- 4.2 AdvaCare Pharma
- 4.2.1 AdvaCare Pharma Company Information
- 4.2.2 AdvaCare Pharma Business Overview
- 4.2.3 AdvaCare Pharma Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AdvaCare Pharma Amodiaquine Tablets Product Portfolio
- 4.2.5 AdvaCare Pharma Recent Developments
- 4.3 DevLife Corporation
- 4.3.1 DevLife Corporation Company Information
- 4.3.2 DevLife Corporation Business Overview
- 4.3.3 DevLife Corporation Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 DevLife Corporation Amodiaquine Tablets Product Portfolio
- 4.3.5 DevLife Corporation Recent Developments
- 4.4 Healthy Life Pharma
- 4.4.1 Healthy Life Pharma Company Information
- 4.4.2 Healthy Life Pharma Business Overview
- 4.4.3 Healthy Life Pharma Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Healthy Life Pharma Amodiaquine Tablets Product Portfolio
- 4.4.5 Healthy Life Pharma Recent Developments
- 4.5 Micro Labs
- 4.5.1 Micro Labs Company Information
- 4.5.2 Micro Labs Business Overview
- 4.5.3 Micro Labs Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Micro Labs Amodiaquine Tablets Product Portfolio
- 4.5.5 Micro Labs Recent Developments
- 4.6 SiNi Pharma
- 4.6.1 SiNi Pharma Company Information
- 4.6.2 SiNi Pharma Business Overview
- 4.6.3 SiNi Pharma Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SiNi Pharma Amodiaquine Tablets Product Portfolio
- 4.6.5 SiNi Pharma Recent Developments
- 4.7 Sunrise
- 4.7.1 Sunrise Company Information
- 4.7.2 Sunrise Business Overview
- 4.7.3 Sunrise Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sunrise Amodiaquine Tablets Product Portfolio
- 4.7.5 Sunrise Recent Developments
- 4.8 Wellona Pharma
- 4.8.1 Wellona Pharma Company Information
- 4.8.2 Wellona Pharma Business Overview
- 4.8.3 Wellona Pharma Amodiaquine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wellona Pharma Amodiaquine Tablets Product Portfolio
- 4.8.5 Wellona Pharma Recent Developments
5 Global Amodiaquine Tablets Market Scenario by Region
- 5.1 Global Amodiaquine Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amodiaquine Tablets Sales by Region: 2021-2032
- 5.2.1 Global Amodiaquine Tablets Sales by Region: 2021-2026
- 5.2.2 Global Amodiaquine Tablets Sales by Region: 2027-2032
- 5.3 Global Amodiaquine Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Amodiaquine Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Amodiaquine Tablets Revenue by Region: 2027-2032
- 5.4 North America Amodiaquine Tablets Market Facts & Figures by Country
- 5.4.1 North America Amodiaquine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amodiaquine Tablets Sales by Country (2021-2032)
- 5.4.3 North America Amodiaquine Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amodiaquine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Amodiaquine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amodiaquine Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Amodiaquine Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amodiaquine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amodiaquine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amodiaquine Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amodiaquine Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amodiaquine Tablets Market Facts & Figures by Country
- 5.7.1 South America Amodiaquine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amodiaquine Tablets Sales by Country (2021-2032)
- 5.7.3 South America Amodiaquine Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Amodiaquine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amodiaquine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amodiaquine Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amodiaquine Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amodiaquine Tablets Sales by Type (2021-2032)
- 6.1.1 Global Amodiaquine Tablets Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Amodiaquine Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Amodiaquine Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Amodiaquine Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amodiaquine Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Amodiaquine Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amodiaquine Tablets Sales by Application (2021-2032)
- 7.1.1 Global Amodiaquine Tablets Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Amodiaquine Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Amodiaquine Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Amodiaquine Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amodiaquine Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Amodiaquine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amodiaquine Tablets Value Chain Analysis
- 8.1.1 Amodiaquine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amodiaquine Tablets Production Mode & Process
- 8.2 Amodiaquine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amodiaquine Tablets Distributors
- 8.2.3 Amodiaquine Tablets Customers
9 Global Amodiaquine Tablets Analyzing Market Dynamics
- 9.1 Amodiaquine Tablets Industry Trends
- 9.2 Amodiaquine Tablets Industry Drivers
- 9.3 Amodiaquine Tablets Industry Opportunities and Challenges
- 9.4 Amodiaquine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst